misonneh's chemotherapy [47 articles] Export

Recent papers added to misonneh's library classified by the tag chemotherapy. You can also see everyone's chemotherapy.

	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy [My Copy] Nature Genetics, Vol. 41, No. 12. (08 November 2009), pp. 1345-1349. by Colin J. D. Ross, Hagit Katzov-Eckert, Marie-Pierre Dube, et al.Beth Brooks, S. Rod Rassekh, Amina Barhdadi, Yassamin Feroz-Zada, Henk Visscher, Andrew M. K. Brown, Michael J. Rieder, Paul C. Rogers, Michael S. Phillips, Bruce C. Carleton, Michael R. Hayden posted to tpmt pharmacogenetics journal_club comt cisplatin chemotherapy association adr by misonneh on 2009-11-25 07:01:55 as
	DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 15, No. 1. (1 January 2009), pp. 315-323. by Oliver Hartmann, Frédérique Spyratos, Nadia Harbeck, et al.Dimo Dietrich, Anne Fassbender, Manfred Schmitt, Serenella Eppenberger-Castori, Vincent Vuaroqueaux, Florence Lerebours, Katrin Welzel, Sabine Maier, Achim Plum, Stephan Niemann, John A. Foekens, Ralf Lesche, John W. Martens posted to time_to_event survival response neoadjuvant methylation gene_specific_methylation chemotherapy breast by misonneh on 2009-11-24 06:40:38 as
	The role of radiotracer imaging in the diagnosis and management of patients with breast cancer: part 2--response to therapy, other indications, and future directions. [My Copy] Journal of nuclear medicine : official publication, Society of Nuclear Medicine, Vol. 50, No. 5. (May 2009), pp. 738-748. by Jean H. Lee, Eric L. Rosen, David A. Mankoff posted to review pet perspective neoadjuvant kim_ chemotherapy breast by misonneh on 2009-11-10 05:17:50 as
	5-methylcytosine--the fifth base of DNA: the fifth wheel on a car or a highly promising diagnostic and therapeutic target in cancer? [My Copy] Disease markers, Vol. 23, No. 1-2. (2007), pp. 1-3. by Martin Widschwendter posted to risk_assessment methylation epigenetics comments chemotherapy biomarker 5mdc by misonneh on 2009-11-04 21:48:18 as
	Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, No. 11. (1 June 2008), pp. 3494-3502. by Heidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger, et al.Georg Hutarew, Roland Reitsamer, Robin L. Jones, Mitch Dowsett, Elisabeth Mueller-Holzner, Gudrun Windbichler, Günter Daxenbichler, Georg Goebel, Christian Ensinger, Ian Jacobs, Martin Widschwendter posted to response prediction pharmacogenetics neurod1 neoadjuvant methylation gene_specific_methylation epigenetics circ_dna chemotherapy breast by misonneh on 2009-11-04 21:21:37 as
	Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas. [My Copy] Molecular cancer, Vol. 8 (14 July 2009), 48. by Elizabeth M. Swisher, Rachel M. Gonzalez, Toshiyasu Taniguchi, et al.Rochelle L. Garcia, Tom Walsh, Barbara A. Goff, Piri Welcsh posted to response prognosis ovarian kim_ gene_specific_methylation expression dna_repair chemotherapy by misonneh on 2009-10-29 08:17:46 as
	Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment. [My Copy] Human genetics (8 October 2009) by Cristina Rodriguez-Antona, Alvin Gomez, Maria Karlgren, Sarah C. Sim, Magnus Ingelman-Sundberg posted to review response prediction methylation kim_ epidgenetics chemotherapy by misonneh on 2009-10-29 07:13:34 as
	The effect of genetic variability on drug response in conventional breast cancer treatment. [My Copy] European journal of pharmacology (18 October 2009) by Emilia Wiechec, Lise Lotte L. Hansen posted to review response pharmacogenetics metabolism genetics chemotherapy breast by misonneh on 2009-10-29 07:12:29 as
	MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma [My Copy] N Engl J Med, Vol. 352, No. 10. (10 March 2005), pp. 997-1003. by Monika E. Hegi, Annie-Claire Diserens, Thierry Gorlia, et al.Marie-France Hamou, Nicolas de Tribolet, Michael Weller, Johan M. Kros, Johannes A. Hainfellner, Warren Mason, Luigi Mariani, Jacoline E. C. Bromberg, Peter Hau, Rene O. Mirimanoff, J. Gregory Cairncross, Robert C. Janzer, Roger Stupp posted to temozolomide response prognosis prediction mgmt kim_ glioblastoma gene_specific_methylation epigenetics chemotherapy alkylating_agents by misonneh on 2009-10-29 07:06:02 as along with 2 people srp33 alanvelander
	Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 3. (6 February 2008), pp. 207-212. by Giuseppe Viale, Meredith M. Regan, Mauro G. Mastropasqua, et al.Fausto Maffini, Eugenio Maiorano, Marco Colleoni, Karen N. Price, Rastko Golouh, Tiziana Perin, R. W. Brown, Anikó Kovács, Komala Pillay, Christian Ohlschlegel, Barry A. Gusterson, Monica Castiglione-Gertsch, Richard D. Gelber, Aron Goldhirsch, Alan S. Coates, International Breast Cancer Study Group posted to prognosis prediction ki67 hormone chemotherapy breast biomarker by misonneh on 2009-10-19 08:47:32 as
	Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 8. (10 March 2008), pp. 1275-1281. by Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess, et al.Fabrice André, Attila Tordai, Jaime A. Mejia, W. Fraser Symmans, Ana M. Gonzalez-Angulo, Bryan Hennessy, Marjorie Green, Massimo Cristofanilli, Gabriel N. Hortobagyi, Lajos Pusztai posted to survival prognosis prediction neoadjuvant chemotherapy breast biomarker by misonneh on 2009-10-19 08:44:43 as
	Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance. [My Copy] Breast cancer research and treatment, Vol. 112, No. 3. (9 December 2008), pp. 475-488. by Djuana M. Harvell, Nicole S. Spoelstra, Meenakshi Singh, et al.James L. McManaman, Christina Finlayson, Tzu Phang, Susan Trapp, Lawrence Hunter, Wendy W. Dye, Virginia F. Borges, Anthony Elias, Kathryn B. Horwitz, Jennifer K. Richer posted to resonse resistance neoadjuvant hormone chemotherapy breast biomarker by misonneh on 2009-10-19 08:44:01 as along with 1 person jfr
	Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast. [My Copy] Breast cancer research : BCR, Vol. 10, No. 2. (01 April 2008), R30. by Gunter von Minckwitz, Hans-Peter P. Sinn, Günter Raab, et al.Sibylle Loibl, Jens-Uwe U. Blohmer, Holger Eidtmann, Jörn Hilfrich, Elisabeth Merkle, Christian Jackisch, Serban D. Costa, Angelika Caputo, Manfred Kaufmann, German Breast Group posted to response neoadjuvant dynamic chemotherapy breast biomarker by misonneh on 2009-10-19 08:42:21 as
	The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer. [My Copy] Breast cancer research and treatment, Vol. 116, No. 1. (1 July 2009), pp. 53-68. by Robin L. Jones, Janine Salter, Roger A'Hern, et al.Ash Nerurkar, Marina Parton, Jorge S. Reis-Filho, Ian E. Smith, Mitchell Dowsett posted to prediction neoadjuvant dynamic chemotherapy breast biomarker by misonneh on 2009-10-19 08:39:43 as along with 1 person Zephyrus
	Changes in tumour biological markers during primary systemic chemotherapy (PST). [My Copy] Anticancer research, Vol. 28, No. 3B. (n 2008), pp. 1797-1804. by Hans Neubauer, Christian Gall, Ulrich Vogel, et al.Rene Hornung, Diethelm Wallwiener, Erich Solomayer, Tanja Fehm posted to response dynamic chemotherapy breast biomarker by misonneh on 2009-10-19 08:37:21 as
	Predicting response to neoadjuvant chemotherapy in breast cancer: molecular imaging, systemic biomarkers and the cancer metabolome (Review). [My Copy] Oncology reports, Vol. 20, No. 4. (October 2008), pp. 699-703. by Suebwong Chuthapisith, Jennifer M. Eremin, Oleg Eremin posted to review response neoadjuvant chemotherapy biomarker by misonneh on 2009-10-19 08:34:52 as
	Tumor-infiltrating lymphocytes predict response to neoadjuvant chemotherapy in patients with breast carcinoma. [My Copy] Cancer investigation, Vol. 26, No. 10. (December 2008), pp. 1024-1031. by Helena Hornychova, Bohuslav Melichar, Marketa Tomsova, Jindøiska Mergancova, Hana Urminska, Ales Ryska posted to response neoadjuvant immunity chemotherapy breast biomarker by misonneh on 2009-10-19 08:17:43 as
	Stromal matrix protein expression following preoperative systemic therapy in breast cancer. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 15, No. 2. (15 January 2009), pp. 731-739. by Anna-Maria M. Tokes, Attila Marcell M. Szasz, Andrea Farkas, et al.Adrienn Ildiko I. Toth, Magdolna Dank, Laszlo Harsanyi, Bela Akos A. Molnar, Istvan Arthur A. Molnar, Zsolt Laszlo, Zoltan Rusz, Janina Kulka posted to stromal_component response neoadjuvant expression chemotherapy breast by misonneh on 2009-10-19 08:13:43 as
	Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma? [My Copy] The breast journal, Vol. 15, No. 2. (r 2009), pp. 146-154. by Peggy S. Sullivan, Sophia K. Apple posted to response neoadjuvant histology chemotherapy breast by misonneh on 2009-10-19 08:04:25 as
	Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 15, No. 12. (15 June 2009), pp. 4234-4241. by Tomonori Tanei, Koji Morimoto, Kenzo Shimazu, et al.Seung Jin J. Kim, Yoshio Tanji, Tetsuya Taguchi, Yasuhiro Tamaki, Shinzaburo Noguchi posted to response resistance neoadjuvant kim_ expression chemotherapy breast aldh1 by misonneh on 2009-10-19 07:55:29 as
	Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy. [My Copy] The oncologist, Vol. 13, No. 12. (December 2008), pp. 1235-1245. by Frédérique Penault-Llorca, Catherine Abrial, Inès Raoelfils, et al.Philippe Chollet, Anne Cayre, Marie-Ange A. Mouret-Reynier, Emilie Thivat, Florence Mishellany, Pierre Gimbergues, Xavier Durando posted to response neoadjuvant expression chemotherapy breast biomarker by misonneh on 2009-10-09 08:42:24 as
	Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27, No. 16. (1 June 2009), pp. 2630-2637. by José Baselga, Vladimir Semiglazov, Peter van Dam, et al.Alexey Manikhas, Meritxell Bellet, José Mayordomo, Mario Campone, Ernst Kubista, Richard Greil, Giulia Bianchi, Jutta Steinseifer, Betty Molloy, Erika Tokaji, Humphrey Gardner, Penny Phillips, Michael Stumm, Heidi A. Lane, J. Michael Dixon, Walter Jonat, Hope S. Rugo posted to response neoadjuvant expression chemotherapy breast by misonneh on 2009-10-09 08:10:36 as
	Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. [My Copy] British journal of cancer, Vol. 92, No. 1. (17 January 2005), pp. 147-155. by R. J. Burcombe, A. Makris, P. I. Richman, et al.F. M. Daley, S. Noble, M. Pittam, D. Wright, S. A. Allen, J. Dove, G. D. Wilson posted to response neoadjuvant expression chemotherapy breast by misonneh on 2009-10-09 08:08:16 as
	Clinical and pathological response to primary chemotherapy in patients with locally advanced breast cancer grouped according to hormonal receptors, Her2 status, grading and Ki-67 proliferation index. [My Copy] Anticancer research, Vol. 29, No. 5. (May 2009), pp. 1621-1625. by Loredana Miglietta, Paola Vanella, Luciano Canobbio, Maria Angela A. Parodi, Pamela Guglielmini, Francesco Boccardo posted to response neoadjuvant expression chemotherapy breast by misonneh on 2009-10-09 08:03:47 as
	Variations in gene expression and response to neoadjuvant chemotherapy in breast carcinoma. [My Copy] Cancer investigation, Vol. 27, No. 5. (June 2009), pp. 521-528. by Romain Boidot, Frédérique Vegran, Marie-Sophie S. Soubeyrand, Pierre Fumoleau, Bruno Coudert, Sarab Lizard-Nacol posted to response neoadjuvant expression chemotherapy breast by misonneh on 2009-10-09 08:00:01 as
	Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 15, No. 14. (15 July 2009), pp. 4712-4721. by Chirayu Shah, Todd W. Miller, Shelby K. Wyatt, et al.Eliot T. McKinley, Maria Graciela G. Olivares, Violeta Sanchez, Donald D. Nolting, Jason R. Buck, Ping Zhao, M. Sib Ansari, Ronald M. Baldwin, John C. Gore, Rachel Schiff, Carlos L. Arteaga, H. Charles Manning posted to response pet neoadjuvant chemotherapy breast by misonneh on 2009-10-09 07:57:35 as
	Epigenetic Therapies Move Into New Territory, but How Exactly Do They Work? [My Copy] J. Natl. Cancer Inst., Vol. 101, No. 19. (7 October 2009), pp. 1300-1301. by Rabiya S. Tuma posted to epigenetics drug_discovery comments chemotherapy by misonneh on 2009-10-07 02:14:53 as
	Role of Anthracyclines in the Treatment of Early Breast Cancer [My Copy] J Clin Oncol, Vol. 27, No. 28. (1 October 2009), pp. 4798-4808. by Luca Gianni, Larry Norton, Norman Wolmark, Thomas M. Suter, Gianni Bonadonna, Gabriel N. Hortobagyi posted to review prognosis pharmacogenetics genetics clinic chemotherapy breast biomarker anthracycline by misonneh on 2009-09-30 04:37:43 as
	Epigenetic Deregulation of DNA Repair and Its Potential for Therapy [My Copy] Clin Cancer Res, Vol. 15, No. 16. (15 August 2009), pp. 5026-5031. by Monika E. Hegi, Davide Sciuscio, Anastasia Murat, Marc Levivier, Roger Stupp posted to review pharmacogenetics genetics epigenetics dna_repair chemotherapy by misonneh on 2009-08-13 07:20:19 as along with 1 person ericrpaquet
	Novel anticancer targets: revisiting ERBB2 and discovering ERBB3 [My Copy] Nat Rev Cancer, Vol. 9, No. 7. (18 July 2009), pp. 463-475. by Jose Baselga, Sandra M. Swain posted to chemotherapy her2 resistance review by misonneh on 2009-07-27 08:56:03 as along with 2 people sschurer renatomilani
	Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? [My Copy] Nat Rev Drug Discov, Vol. 8, No. 7. (29 July 2009), pp. 579-591. by Dunyaporn Trachootham, Jerome Alexandre, Peng Huang posted to chemotherapy moa ros by misonneh on 2009-07-22 03:32:36 as along with 1 person and 1 group Zephyrus Roswell Cancer Crosstalk
	Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer [My Copy] J Clin Oncol, Vol. 27, No. 20. (10 July 2009), pp. 3297-3302. by Sao Jiralerspong, Shana L. Palla, Sharon H. Giordano, et al.Funda Meric-Bernstam, Cornelia Liedtke, Chad M. Barnett, Limin Hsu, Mien-Chie Hung, Gabriel N. Hortobagyi, Ana M. Gonzalez-Angulo posted to breast chemotherapy diabetes metformin pathology response by misonneh on 2009-07-13 10:12:12 as
	Pharmacogenetics and cancer therapy [My Copy] Nat Rev Cancer, Vol. 1, No. 2. (November 2001), pp. 99-108. by Mary V. Relling, Thierry Dervieux posted to chemotherapy pharmacogenetics review by misonneh on 2009-06-04 05:34:04 as
	Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 27. (20 September 2008), pp. 4449-4457. by L. K. Dunnwald, J. R. Gralow, G. K. Ellis, et al.R. B. Livingston, H. M. Linden, J. M. Specht, R. K. Doot, T. J. Lawton, W. E. Barlow, B. F. Kurland, E. K. Schubert, D. A. Mankoff posted to breast chemotherapy fu metabolism neoadjuvant outcome pet response by misonneh on 2009-05-20 06:14:24 as
	Targeting multidrug resistance in cancer [My Copy] Nature Reviews Drug Discovery, Vol. 5, No. 3., pp. 219-234. by Gergely Szakács, Jill K. Paterson, Joseph A. Ludwig, Catherine Booth-Genthe, Michael M. Gottesman posted to cancer chemotherapy moa resistance review by misonneh on 2009-04-10 09:58:34 as along with 2 people happy_manatee Petersarkies
	Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy? [My Copy] J. Natl. Cancer Inst., Vol. 100, No. 11. (4 June 2008), pp. 773-783. by Brian D. Lawenda, Kara M. Kelly, Elena J. Ladas, Stephen M. Sagar, Andrew Vickers, Jeffrey B. Blumberg posted to antioxidant chemoprevention chemotherapy diet survival by misonneh on 2009-03-17 11:01:00 as along with 1 person tamimi
	A Century of Deciphering the Control Mechanisms of Sex Steroid Action in Breast and Prostate Cancer: The Origins of Targeted Therapy and Chemoprevention [My Copy] Cancer Res, Vol. 69, No. 4. (15 February 2009), pp. 1243-1254. by Craig V. Jordan posted to aromatase_inhibitor breast chemotherapy hormone moa prevention prostate review tamoxifen by misonneh on 2009-02-25 01:03:38 as
	Beyond chemotherapy: targeted therapies in ovarian cancer [My Copy] Nat Rev Cancer, Vol. 9, No. 3. (March 2009), pp. 167-181. by Timothy A. Yap, Craig P. Carden, Stan B. Kaye posted to chemotherapy ovary pharmacogenetics review toxicity by misonneh on 2009-02-25 01:00:28 as
	Advances in the Treatment of Breast Cancer [My Copy] Clin Pharmacol Ther, Vol. 83, No. 1. (19 December 2007), pp. 26-36. by S. Moulder, G. N. Hortobagyi posted to breast chemotherapy review by misonneh on 2009-01-23 06:41:45 as along with 1 group Breast Cancer Reading Club
	CYP450 pharmacogenetics for personalizing cancer therapy. [My Copy] Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, Vol. 11, No. 3. (June 2008), pp. 77-98. by R. H. van Schaik posted to breast chemotherapy pharmacogenetics review tamoxifen cyp450 by misonneh on 2009-01-23 06:20:27 as
	Pharmacogenetics in breast cancer therapy. [My Copy] Clinical Cancer Research, Vol. 14, No. 24. (15 December 2008), pp. 8027-8041. by S. H. Tan, S. C. Lee, B. C. Goh, J. Wong posted to breast chemotherapy pharmacogenetics review tamoxifen by misonneh on 2009-01-23 05:48:50 as along with 3 people and 2 groups HyeEun-Jeong songpku Zephyrus Asian Pharmacogenetics Library Breast Cancer Reading Club
	Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897. [My Copy] Journal of Clinical Oncology, Vol. 26, No. 8. (10 March 2008), pp. 1223-1230. by P. A. Ganz, M. A. Hussey, C. M. Moinpour, et al.J. M. Unger, L. F. Hutchins, S. R. Dakhil, J. K. Giguere, J. W. Goodwin, S. Martino, K. S. Albain posted to breast chemotherapy pharmacogenetics s8897 by misonneh on 2009-01-22 04:31:39 as
	A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, No. 49. (December 2008), pp. 19432-19437. by Katherine S. Garman, Chaitanya R. Acharya, Elena Edelman, et al.Marian Grade, Jochen Gaedcke, Shivani Sud, William Barry, Anna M. Diehl, Dawn Provenzale, Geoffrey S. Ginsburg, Michael B. Ghadimi, Thomas Ried, Joseph R. Nevins, Sayan Mukherjee, David Hsu, Anil Potti posted to chemotherapy colon expression microarray pharmacogenetics by misonneh on 2008-12-29 07:20:36 as along with 2 people jfr sg45653
	Cellular and Molecular Pharmacology of Antiestrogen Action and Resistance [My Copy] Pharmacol Rev, Vol. 53, No. 1. (1 March 2001), pp. 25-72. by Robert Clarke, Fabio Leonessa, James N. Welch, Todd C. Skaar posted to chemotherapy resistance review tamoxifen by misonneh on 2008-12-09 04:03:38 as along with 1 person Zephyrus
	Chemoprevention of prostate cancer: agents and study designs. [My Copy] Journal of Urology, Vol. 178, No. 3 Pt 2. (September 2007) by I. M. Thompson posted to chemotherapy prostate review by misonneh on 2008-10-29 10:34:04 as
	Don Quixote and the quest for personalized medicine. [My Copy] Journal of Clinical Oncology, Vol. 26, No. 16. (1 June 2008), pp. 2619-2620. by C. J. Allegra, J. K. Benedetti posted to chemotherapy colon comments pharmacogenetics by misonneh on 2008-10-29 10:20:25 as along with 1 person and 1 group Zephyrus Roswell Cancer Crosstalk
	Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial. [My Copy] Journal of Clinical Oncology, Vol. 26, No. 16. (1 June 2008), pp. 2690-2698. by M. S. Braun, S. D. Richman, P. Quirke, et al.C. Daly, J. W. Adlard, F. Elliott, J. H. Barrett, P. Selby, A. M. Meade, R. J. Stephens, M. K. Parmar, M. T. Seymour posted to biomarker chemotherapy clinic colon pharmacogenetics by misonneh on 2008-10-29 10:19:17 as

Note: You may cite this page as: http://www.citeulike.org/user/misonneh/tag/chemotherapy

review	305
breast	260
genetics	162
epigenetics	161
methylation	153
pharmacogenetics	126
statistics	87
gene_specific_methylation	66
comments	65
gwas	63
biomarker	62
prognosis	60
association	53
tamoxifen	53
chemotherapy	47
moa	47
peripheral	47
gxe	46
diet	43
folate	40
modeling	38
guideline	35
resistance	35
survival	35
meta_analysis	34
global	33
prediction	33
response	32
epidemiology	31
epistasis	30
adr	29
dynamic	28
korean	28
technology	27
diagnosis	26
haplotype	26
prostate	26
time_to_event	25
cyp2d6	23
expression	23
race	23
neoadjuvant	22
circ_dna	21
colon	21
instability	21
environment	20
database	19
prevention	19
progression	18
lung	17
perspective	17
risk_factor	17
line1	16
pooling	16
therapy	16
immunity	14
target_dna	14
1-carbon	13
clinic	13
hr	13
invivo	13
phenotype	13
tool	13
5mdc	12
age	12
randomized_controlled_trial	12
tutorial	12
gxg	11
hematology	11
metastasis	11
mirna	11
pk	11
bladder	10
data_mining	10
estrogen	10
exposure	9
hormone	9
pathway	9
smoking	9
bias	8
cancer	8
design	8
esr1	8
fda	8
gst	8
heterogeneity	8
ivive	8
lifestyle	8
reproductive	8
cnv	7
dnmt	7
etiology	7
her2	7
hla	7
kim_	7
mdr1	7
metabolism	7
mthfr	7
power	7
prenatal	7
subtypes	7
trend	7
alcohol	6
carbamazepine	6
cell	6
cohort	6
cyp450	6
ddi	6
dna_repair	6
drug_discovery	6
epilepsy	6
histone	6
hyper_hypo	6
maternal	6
pcb	6
summary	6
system_biology	6
array	5
benign	5
cervix	5
chemoprevention	5
fundamental_concept_s1	5
inheritance	5
intervention	5
methodology	5
mgmt	5
mhc	5
microarray	5
mortality	5
nos3	5
pet	5
translation	5
asian_populations	4
balanced	4
basal-like	4
biobank	4
bmd	4
cimp	4
cns	4
detection	4
disparities	4
leukemia	4
linkage	4
ntissue	4
observation	4
pathology	4
refractory	4
transport	4
triple-negative	4
tsnp	4
aml	3
antioxidant	3
cluster	3
cyp1a1	3
cytokine	3
demethylation	3
fu	3
glioblastoma	3
hitchhiking	3
intrauterine	3
mds	3
metformin	3
molecular	3
public	3
ros	3
statin	3
sult1a1	3
sult1e1	3
swog	3
toxicity	3
validation	3
allergy	2
apoptosis	2
aromatase_inhibitor	2
aspirin	2
atm	2
bayesian	2
benzopyrene	2
bisphenol	2
brain	2
brca	2
brca12	2
caret	2
childhood	2
classification	2
comt	2
consorcium	2
cyp2c19	2
cyp2e1	2
decitabine	2
definition	2
diabetes	2
egfr_pathway	2
endometrix	2
epigenetic_therapy	2
feature_selection	2
finasteride	2
fprp	2
genotype	2
grail	2
hematopoiety	2
immortalization	2
insilico	2
irinotecan	2
iron	2
isoflavone	2
kawasaki	2
key	2
lymphoma	2
mnsod	2
nqo1	2
nutrition	2
oral	2
ovarian	2
ovary	2
parent_study	2
pharmacodynamic	2
phase	2
polycomb	2
protocol	2
quantitative_traits	2
radiotherapy	2
risk_assessment	2
s8897	2
slco1b1	2
specimen	2
testicular	2
toxicology	2
tpmt	2
ugt	2
wnt	2
abacavir	1
acs	1
aldh1	1
aldh2	1
alkylating_agents	1
alternative	1
anthracycline	1
antidepressant	1
assay	1
azacitidine	1
benzene	1
bmp	1
casp8	1
cat	1
catechol	1
cbr3	1
cdk	1
cell_cycle_control	1
cisplatin	1
cml	1
compliance	1
confounder	1
consortium	1
cyclophosphamide	1
cyp19	1
cyp1a2	1
cyp1b1	1
cyp2c9	1
cyp3a4	1
dag	1
dcic	1
decision	1
diganosis	1
digoxin	1
ecadherin	1
endpoint	1
epidgenetics	1
example	1
family_hx	1
fastsnp	1
fmr1	1
fun	1
glioma	1
gpx1	1
gstp1	1
heritability	1
hif1a	1
histology	1
history	1
hnscc	1
ho1	1
hogg1	1
hpv	1
illumina	1
immunoprecipitation	1
index	1
infection	1
inflammtion	1
integration	1
interleukin	1
invitro	1
journal_club	1
ki67	1
lactation	1
lipidadjust	1
liver	1
mapping	1
maspin	1
mbd2	1
metabolomics	1
meternal	1
methotrexate	1
mining	1
mpo	1
mrp3	1
multiple_myeloma	1
multitest	1
myc	1
networking	1
neurod1	1
nhs	1
no	1
nrf2	1
nsaid	1
nuclear_receptor	1
obesity	1
oncotypedx	1
opg	1
oralscc	1
osteoporosis	1
outcome	1
p53	1
parity	1
paternal	1
pax2	1
peakbmd	1
peripheral_blood	1
pharmacogenomics	1
pharmacokinetic_variability	1
phytoestrogen	1
plink	1
polymapr	1
polyphenol	1
population	1
practice	1
prevalence	1
proression	1
psychoses	1
qsar	1
rank	1
rcc	1
read_	1
resonse	1
rfc	1
s100p	1
sat2	1
scn	1
series	1
sfrp5	1
silencing_rna	1
splicing	1
sputum	1
src	1
steroid	1
stromal_component	1
tea	1
temozolomide	1
tgf	1
tgm2	1
tp53	1
twin_study	1
ugt1a1	1
warfarin	1
xpd	1
xrcc1	1
xrcc3	1

misonneh's chemotherapy [47 articles] Export

misonneh's tags